CLINICAL SIGNIFICANCE OF CIRCULATING C-PEPTIDE IN DIABETES-MELLITUS AND HYPOGLYCEMIC DISORDERS

被引:59
|
作者
RUBENSTEIN, AH [1 ]
KUZUYA, H [1 ]
HORWITZ, DL [1 ]
机构
[1] UNIV CHICAGO,DEPT MED,ENDOCRINOL SECT,CHICAGO,IL 60637
关键词
D O I
10.1001/archinte.137.5.625
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:625 / 632
页数:8
相关论文
共 50 条
  • [21] PLASMA C-PEPTIDE RESPONSE TO GLUCAGON AS A MEASURE OF B-CELL FUNCTION IN DIABETES-MELLITUS
    HENDRIKSEN, C
    DREJER, J
    DIABETOLOGIA, 1976, 12 (04) : 397 - 397
  • [22] CLINICAL SIGNIFICANCE OF THE RADIOIMMUNOLOGICAL DETERMINATION OF C-PEPTIDE
    DUDCZAK, R
    WALDHAUSL, W
    WIENER KLINISCHE WOCHENSCHRIFT, 1979, 91 (19) : 658 - 662
  • [23] ORAL HYPOGLYCEMIC AGENTS IN DIABETES-MELLITUS
    GRIMES, DS
    LANCET, 1975, 2 (7935): : 616 - 616
  • [24] HYPOGLYCEMIC ACTION OF FENFLURAMINE IN DIABETES-MELLITUS
    TURTLE, JR
    BURGESS, JA
    DIABETES, 1973, 22 (11) : 858 - 867
  • [25] HYPOGLYCEMIC EFFECT OF NICOTINAMIDE IN DIABETES-MELLITUS
    OBROSOVA, IG
    EFIMOV, AS
    VELIKY, NN
    AVRAMENKO, NL
    ZUBKOVA, ST
    ZUYEVA, NA
    KHOVAKA, VV
    FARMAKOLOGIYA I TOKSIKOLOGIYA, 1987, 50 (02): : 113 - 115
  • [26] DIABETES-MELLITUS AND THE HYPOGLYCEMIC AGENTS IN THE ELDERLY
    RICKETTS, HT
    JOURNALS OF GERONTOLOGY, 1961, 16 (04): : 398 - 398
  • [27] C-Peptide as a Therapy for Type 1 Diabetes Mellitus
    Washburn, Rachel L.
    Mueller, Karl
    Kaur, Gurvinder
    Moreno, Tanir
    Moustaid-Moussa, Naima
    Ramalingam, Latha
    Dufour, Jannette M.
    BIOMEDICINES, 2021, 9 (03) : 1 - 24
  • [28] C-Peptide and Atherogenesis: C-Peptide as a Mediator of Lesion Development in Patients with Type 2 Diabetes Mellitus?
    Marx, Nikolaus
    Walcher, Daniel
    EXPERIMENTAL DIABETES RESEARCH, 2008, : 385108
  • [30] CIRCULATING C-PEPTIDE - MEASUREMENT AND CLINICAL-APPLICATION
    ASHBY, JP
    FRIER, BM
    ANNALS OF CLINICAL BIOCHEMISTRY, 1981, 18 (MAY) : 125 - 130